Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Prognostic Significance of Ki-67 Antigen Expression in Non-Hodgkin's Lymphomas

KATARZYNA SZCZURASZEK, GRZEGORZ MAZUR, MICHAL JELEŃ, PIOTR DZIĘGIEL, PAWEL SUROWIAK and MACIEJ ZABEL
Anticancer Research March 2008, 28 (2A) 1113-1118;
KATARZYNA SZCZURASZEK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kasiasz@ak.am.wroc.pl
GRZEGORZ MAZUR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAL JELEŃ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PIOTR DZIĘGIEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAWEL SUROWIAK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MACIEJ ZABEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 2A 1113-1118

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 16, 2007
  • Revision received January 11, 2008
  • Accepted February 5, 2008
  • Published online March 1, 2008.

Copyright & Usage 
Copyright© 2008 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. KATARZYNA SZCZURASZEK1,
  2. GRZEGORZ MAZUR2,
  3. MICHAL JELEŃ3,
  4. PIOTR DZIĘGIEL1,
  5. PAWEL SUROWIAK1 and
  6. MACIEJ ZABEL1,4
  1. 1Department of Histology and Embryology, University School of Medicine, Wroclaw
  2. 2Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, University School of Medicine, Wroclaw
  3. 3Department of Pathological Anatomy, University School of Medicine, Wroclaw
  4. 4Department of Histology and Embryology, Medical University, Poznań, Poland
  1. Correspondence to: Katarzyna Szczuraszek, Ph.D., Department of Histology and Embryology, University School of Medicine, ul.Chalubinskiego 6a, 50-368 Wroclaw, Poland. Tel: +48 71 7841354, Fax: +48 71 7840082, e-mail: kasiasz{at}ak.am.wroc.pl

Cited By...

  • 32 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 28 (2A)
Anticancer Research
Vol. 28, Issue 2A
March-April 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Significance of Ki-67 Antigen Expression in Non-Hodgkin's Lymphomas
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Significance of Ki-67 Antigen Expression in Non-Hodgkin's Lymphomas
KATARZYNA SZCZURASZEK, GRZEGORZ MAZUR, MICHAL JELEŃ, PIOTR DZIĘGIEL, PAWEL SUROWIAK, MACIEJ ZABEL
Anticancer Research Mar 2008, 28 (2A) 1113-1118;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Significance of Ki-67 Antigen Expression in Non-Hodgkin's Lymphomas
KATARZYNA SZCZURASZEK, GRZEGORZ MAZUR, MICHAL JELEŃ, PIOTR DZIĘGIEL, PAWEL SUROWIAK, MACIEJ ZABEL
Anticancer Research Mar 2008, 28 (2A) 1113-1118;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma
  • Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas
  • The Expression of MT1 Melatonin Receptor and Ki-67 Antigen in Melanoma Malignum
  • Google Scholar

More in this TOC Section

  • The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
  • Ephrin Receptor A4 Expression Enhances Migration, Invasion and Neurotropism in Pancreatic Ductal Adenocarcinoma Cells
  • Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2021 Anticancer Research

Powered by HighWire